Aadi Bioscience
Clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Learn more
Launch date
Employees
Market cap
$44.3m
Enterprise valuation
($33m) (Public information from Sep 2024)
Share price
$1.93 AADI
Los Angeles California (HQ)
Authorizing premium user...